Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?

Tumor-infiltrating T lymphocytes (TILs) are observed in a number of human primary or metastatic tumors. Recently, gene expression profiling experiments suggested that the presence of T cells in metastatic melanomas before vaccinating the patients with tumor antigens could be a biomarker for clinical...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer Immunology, Immunotherapy Jg. 60; H. 8; S. 1153 - 1160
Hauptverfasser:	Cipponi, Arcadi, Wieers, Grégoire, van Baren, Nicolas, Coulie, Pierre G.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Berlin/Heidelberg Springer-Verlag 01.08.2011 Springer Springer Nature B.V
Schlagworte:	Animals Antigens Antigens, Neoplasm - immunology Antineoplastic agents Biological and medical sciences Biomarkers Biomarkers, Pharmacological - metabolism Biopsy Cancer Cancer Research Cancer Vaccines Dermatology Focussed Research Review Gene expression Gene Expression Profiling Humans Immunization Immunology Immunotherapy Lymphatic system Lymphocytes Lymphocytes, Tumor-Infiltrating - immunology Medical prognosis Medical research Medical sciences Medicine Medicine & Public Health Melanoma Melanoma - diagnosis Melanoma - immunology Melanoma - pathology Metastasis Multivariate analysis Neoplasm Metastasis Oncology Patient Selection Patients Pharmacology. Drug treatments Prognosis Skin Neoplasms - diagnosis Skin Neoplasms - immunology Skin Neoplasms - pathology Tumors Tumors of the skin and soft tissue. Premalignant lesions Vaccines Belgium PIVAC 10 Prognosis T lymphocyte Immunotherapy Melanoma Human Patient Tumor infiltrating lymphocyte Malignant tumor Treatment T-Lymphocyte Malignant melanoma Cancer
ISSN:	0340-7004, 1432-0851, 1432-0851
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!